These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10672917)

  • 1. Renal replacement therapy in the elderly: medical, ethical, and psychosocial considerations.
    Stack AG; Messana JM
    Adv Ren Replace Ther; 2000 Jan; 7(1):52-62. PubMed ID: 10672917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of elderly patients with diabetes and end-stage renal disease.
    Goldfarb-Rumyantzev AS; Rout P
    Semin Dial; 2010; 23(2):185-90. PubMed ID: 20374551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in the elderly ESRD patient.
    Calkins ME
    ANNA J; 1993 Oct; 20(5):569-71. PubMed ID: 8285798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
    Friedlander MA; Hricik DE
    Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal replacement therapy in the elderly population.
    Berger JR; Hedayati SS
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):1039-46. PubMed ID: 22516288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, management, and outcomes of end-stage renal disease in the elderly.
    Kurella Tamura M
    Curr Opin Nephrol Hypertens; 2009 May; 18(3):252-7. PubMed ID: 19374012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide demographics and future trends of the management of renal failure in the elderly.
    Mignon F; Michel C; Mentre F; Viron B
    Kidney Int Suppl; 1993 Jun; 41():S18-26. PubMed ID: 8320916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal replacement therapy in the United States: data from the United States Renal Data System.
    Agodoa LY; Eggers PW
    Am J Kidney Dis; 1995 Jan; 25(1):119-33. PubMed ID: 7810518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy in haemodialysis patients. Special considerations in the elderly.
    St Peter WL; Clark JL; Levos OM
    Drugs Aging; 1998 Jun; 12(6):441-59. PubMed ID: 9638393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
    Hörl WH; de Alvaro F; Williams PF
    Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly diabetic patients on peritoneal dialysis.
    Passadakis P; Oreopoulos DG
    Adv Perit Dial; 2009; 25():140-6. PubMed ID: 19886336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparities in renal replacement therapy.
    Gadegbeku C; Freeman M; Agodoa L
    J Natl Med Assoc; 2002 Aug; 94(8 Suppl):45S-54S. PubMed ID: 12152912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease in Canada: prevalence projections to 2005.
    Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS
    CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.